[1] WEN H, VUITTON L, TUXUN T, et al.Echinococcosis: Advances in the 21st Century[J].Clin Microbiol Rev,2019,32(2):e18-e75. [2] KAWAMURA N, KAMIYAMA T, SATO N, et al.Long-term results of hepatectomy for patients with alveolar echinococcosis: a single-center experience[J]. J Am Coll Surg, 2011, 212(5):804-812. [3] 温浩, 徐明谦. 实用包虫病学[M]. 北京:科学出版社, 2007. [4] 中国医师协会外科医师分会包虫病外科专业委员会.肝两型包虫病诊断与治疗专家共识(2019版)[J].中华消化外科杂志, 2019, 18(8):711-721. [5] 李涛, 王翔, 张伟, 等. 脑泡型棘球蚴病的诊疗研究进展[J].四川医学, 2022, 43(7):726-729. [6] 邹铭西. MAC387抗原在炎性皮肤病及皮肤肿瘤中角朊细胞的表达[J]. 中华皮肤科杂志, 1992, 25(1):16-18. [7] ANTONIADES CG, QUAGLIA A, TAAMS LS, et al.Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans[J].Hepatology, 2012, 56(2):735-746. [8] 刘曼, 张红霞, 周璐, 等. 受体相互作用蛋白3介导自身免疫性肝炎肝脏单核细胞来源巨噬细胞募集[J].中华消化杂志, 2021, 41(1):35-42. [9] 朱国贞. 对人类IgA肾病间质小管的炎性细胞浸润的研究[D]. 山西:山西医科大学, 2004. [10] 玉苏甫卡迪尔•麦麦提尼加提, 艾麦提•牙森, 张瑞青, 等. 多房棘球蚴感染早期肝纤维化的实验动物研究[J]. 新疆医科大学学报, 2020, 43(5):558-561,566. [11] KRENKEL O, PUENGEL T, GOVAERE O, et al.Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis[J]. Hepatology, 2018, 67(4):1270-1283. [12] TACKE F, ZIMMERMANN HW.Macrophage heterogeneity in liver injury and fibrosis[J]. J Hepatol, 2014, 60(5):1090-1096. [13] KARLMARK KR, WEISKIRCHEN R, ZIMMERMANN HW, et al.Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis[J].Hepatology, 2009, 50(1):261-274. [14] KLEIN I, CORNEJO JC, POLAKOS NK, et al.Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages[J]. Blood, 2007, 110(12):4077-4085. [15] JENKINS SJ, RUCKERL D, COOK PC, et al.Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation[J]. Science, 2011, 332(6035):1284-1288. [16] GORDON S, MARTINEZ FO.Alternative activation of macrophages: mechanism and functions[J]. Immunity, 2010, 32(5):593-604. [17] HUANG R, WU H, LIU Y, et al.Increase of infiltrating monocytes in the livers of patients with chronic liver diseases[J]. Discov Med, 2016, 21(113):25-33. [18] CASULLI A, BARTH TFE, TAMAROZZI F.Echinococcus multilocularis[J]. Trends Parasitol, 2019, 35(9):738-739. [19] KERN P, WEN H, SATO N, et al. WHO classification of alveolar echinococcosis: principles and application[J].Parasitol Int, 2006, 55 Suppl:S283-S287. [20] ZHANG C, LIN R, LI Z, et al.Immune Exhaustion of T Cells in Alveolar Echinococcosis Patients and Its Reversal by Blocking Checkpoint Receptor TIGIT in a Murine Model[J].Hepatology, 2020, 71(4):1297-1315. [21] WANG H, ZHANG CS, FANG BB, et al.Dual Role of Hepatic Macrophages in the Establishment of the Echinococcus multilocularis Metacestode in Mice[J]. Front Immunol, 2021, 11:600635. [22] SCHEUER PJ.Classification of chronic viral hepatitis: a need for reassessment[J]. J Hepatol, 1991, 13(3):372-374. [23] RAO J, WANG H, NI M, et al.FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2[J]. Gut, 2022, 71(12): 2539-2550. [24] CAO D, XU H, GUO G, et al.Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure[J]. Inflammation, 2013, 36(1):110-120. [25] ECKE TH, KIANI A, SCHLOMM T, et al.Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy[J]. Int J Mol Sci, 2020, 21(19):7420. [26] BRESSON-HADNI S, SPAHR L, CHAPPUIS F.Hepatic Alveolar Echinococcosis[J]. Semin Liver Dis, 2021, 41(3):393-408. [27] 郭悦承, 蔡晓波, 陆伦根. 巨噬细胞在肝纤维化进展和消退中的作用[J]. 国际消化病杂志, 2022, 42(3):163-166. [28] LIU Y, TIAN F, SHAN J, et al.Kupffer Cells: Important Participant of Hepatic Alveolar Echinococcosis[J]. Front Cell Infect Microbiol, 2020, 10:8. [29] GUILLIAMS M, MILDNER A, YONA S.Developmental and Functional Heterogeneity of Monocytes[J].Immunity, 2018, 49(4):595-613. [30] TACKE F.Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo[J]. Fibrogenesis Tissue Repair, 2012, 5(Suppl 1):S27. [31] TACKE F.Targeting hepatic macrophages to treat liver diseases[J]. J Hepatol, 2017, 66(6):1300-1312. |